NorthX Biologics

NorthX Biologics is a Swedish CDMO with more than 30 years of GMP experience in advanced biologics, operating from two sites in Matfors and Stockholm. In 2021, the company was designated by the Swedish Government as a national competence centre for advanced biologics and gene therapies. 

Guided by its Beyond CDMO philosophy, NorthX Biologics acts as an extension of its partners’ teams, combining scientific expertise with a collaborative and flexible way of working. The company supports clients with integrated services from cell line development and process development through to GMP manufacturing and commercial supply. Its capabilities span recombinant proteins, extracellular vesicles, plasmid DNA, vaccines, viral vectors, cell therapies, as well as aseptic fill and finish. 

www.nxbio.com